{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T22:28:17Z","timestamp":1779316097241,"version":"3.51.4"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2020,6,4]],"date-time":"2020-06-04T00:00:00Z","timestamp":1591228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,4]],"date-time":"2020-06-04T00:00:00Z","timestamp":1591228800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Colorectal Dis"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s00384-020-03640-9","type":"journal-article","created":{"date-parts":[[2020,6,4]],"date-time":"2020-06-04T21:02:42Z","timestamp":1591304562000},"page":"1855-1864","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Management of anal intraepithelial neoplasia and anal squamous cell carcinoma at a tertiary referral centre with a dedicated infectious diseases unit: an 18-year review"],"prefix":"10.1007","volume":"35","author":[{"given":"M.","family":"Power Foley","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. E.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Kerr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Gallagher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Gillham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B. J.","family":"Mehigan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. H.","family":"McCormick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Bergin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. O.","family":"Larkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,6,4]]},"reference":[{"issue":"5","key":"3640_CR1","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.currproblcancer.2018.11.001","volume":"42","author":"M Morton","year":"2018","unstructured":"Morton M, Melnitchouk N, Bleday R (2018) Squamous cell carcinoma of the anal canal. Curr Probl Cancer. 42(5):486\u2013492. https:\/\/doi.org\/10.1016\/j.currproblcancer.2018.11.001 Epub 2018 Nov 23","journal-title":"Curr Probl Cancer."},{"key":"3640_CR2","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1158\/1055-9965.EPI-15-0044","volume":"24","author":"MS Shiels","year":"2015","unstructured":"Shiels MS, Kreimer AR, Coghill AE, Darragh TM, Devesa SS (2015) Anal cancer incidence in the United States, 1977\u20132011: distinct patterns by histology and behavior. Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol 24:1548\u20131556. https:\/\/doi.org\/10.1158\/1055-9965.EPI-15-0044","journal-title":"Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol"},{"key":"3640_CR3","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1200\/JCO.2012.45.2524","volume":"31","author":"RA Nelson","year":"2013","unstructured":"Nelson RA, Levine AM, Bernstein L, Smith DD, Lai LL (2013) Changing patterns of anal canal carcinoma in the United States. J Clin Oncol 31:1569\u20131575","journal-title":"J Clin Oncol"},{"key":"3640_CR4","unstructured":"Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) Research Data (1973-2015), Na- tional Cancer Institute, DCCPS, Surveillance Research Program, released April 2018, based on the November 2017 sub- mission. Anal Cancer, (1973-2009)."},{"key":"3640_CR5","unstructured":"National Cancer Registry of Ireland (2017). Cancer Trends No. 33. HPV-associated cancers. NCR, Cork, Ireland"},{"key":"3640_CR6","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.soc.2003.12.005","volume":"13","author":"ML Welton","year":"2004","unstructured":"Welton ML, Sharkey FE, Kahlenberg MS (2004) The etiology and epidemiology of anal cancer. Surg Oncol Clin N Am 13:263\u2013275","journal-title":"Surg Oncol Clin N Am"},{"issue":"2","key":"3640_CR7","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1002\/cncr.20365","volume":"101","author":"JR Daling","year":"2004","unstructured":"Daling JR, Madeleine MM, Johnson LG, Schwartz SM, Shera KA, Wurscher MA, Carter JJ, Porter PL, Galloway DA, McDougall JK (2004) Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer. Cancer. 101(2):270\u2013280","journal-title":"Cancer."},{"key":"3640_CR8","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1002\/ijc.25080","volume":"127","author":"KG Sunesen","year":"2010","unstructured":"Sunesen KG, N\u00f8rgaard M, Thorlacius-Ussing O, Laurberg S (2010) 2010, N\u00f8rgaard M, Thorlacius-Ussing O, Laurberg S. Immunosuppressive disorders and risk of anal squamous cell carcinoma: a nationwide cohort study in Denmark, 1978\u20132005. Int J Cancer 127:675\u2013684. https:\/\/doi.org\/10.1002\/ijc.25080","journal-title":"Int J Cancer"},{"key":"3640_CR9","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1093\/cid\/cir1012","volume":"54","author":"MJ Silverberg","year":"2012","unstructured":"Silverberg MJ, Lau B, Justice AC, Engels E, Gill MJ, Goedert JJ, Kirk GD, D'Souza G, Bosch RJ, Brooks JT, Napravnik S, Hessol NA, Jacobson LP, Kitahata MM, Klein MB, Moore RD, Rodriguez B, Rourke SB, Saag MS, Sterling TR, Gebo KA, Press N, Martin JN, Dubrow R, the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of IeDEA (2012) Risk of anal cancer in HIV-Infected and HIV-uninfected Individuals in North America. Clin Infect Dis Off Publ Infect Dis Soc Am 54:1026\u20131034. https:\/\/doi.org\/10.1093\/cid\/cir1012","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"3640_CR10","unstructured":"WWY Tong, RJ Hillman, AD Kelleher, AE Grulichand A Carr. Anal intraepithelial neoplasia and squamous cell carcinoma in HIV-infected adults;"},{"key":"3640_CR11","first-page":"753","volume":"59","author":"M Frisch","year":"1999","unstructured":"Frisch M, Fenger C, van den Brule AJ, S\u00f8rensen P, Meijer CJ, Walboomers JM, Adami HO, Melbye M, Glimelius B (1999) Variants of squamous cell car- cinoma of the anal canal and perianal skin and their relation to human pap- illomaviruses. Cancer Res 59:753\u2013757","journal-title":"Cancer Res"},{"key":"3640_CR12","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1002\/ijc.25825","volume":"129","author":"H-Y Yhim","year":"2011","unstructured":"Yhim H-Y, Lee N-R, Song E-K, Kwak J-Y, Lee ST, Kim JH, Kim JS, Park HS, Chung IJ, Shim HJ, Hwang JE, Kim HR, Nam TK, Park MR, Shim H, Park HS, Kim HS, Yim CY (2011) The prognostic significance of tumor human papillomavirus status for patients with anal squamous cell carcinoma treated with combined chemoradiotherapy. Int J Cancer 129:1752\u20131760. https:\/\/doi.org\/10.1002\/ijc.25825","journal-title":"Int J Cancer"},{"key":"3640_CR13","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.canep.2013.09.015","volume":"37","author":"N Ouhoummane","year":"2013","unstructured":"Ouhoummane N, Steben M, Coutl\u00e9e F, Vuong T, Forest P, Rodier C, Louchini R, Duarte E, Brassard P (2013) Squamous anal cancer: patient characteristics and HPV type distribution. Cancer Epidemiol 37:807\u2013812. https:\/\/doi.org\/10.1016\/j.canep.2013.09.015","journal-title":"Cancer Epidemiol"},{"key":"3640_CR14","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1056\/NEJM199711063371911","volume":"337","author":"KV Shah","year":"1997","unstructured":"Shah KV (1997) Human papillomaviruses and anogenital cancers. N Engl J Med 337:1386\u20131388. https:\/\/doi.org\/10.1056\/NEJM199711063371911","journal-title":"N Engl J Med"},{"key":"3640_CR15","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1002\/ijc.25671","volume":"129","author":"L Abramowitz","year":"2011","unstructured":"Abramowitz L, Jacquard AC, Jaroud F, Haesebaert J, Siproudhis L, Pradat P, Aynaud O, Leocmach Y, Soubeyrand B, Dachez R, Riethmuller D, Mougin C, Pretet JL, Denis F (2011) Human papillomavirus genotype distribution in anal cancer in France: the EDiTH V study. Int J Cancer 129:433\u2013439. https:\/\/doi.org\/10.1002\/ijc.25671","journal-title":"Int J Cancer"},{"issue":"Suppl 3","key":"3640_CR16","first-page":"S3\/11","volume":"24","author":"DM Parkin","year":"2006","unstructured":"Parkin DM, Bray F (2006) Chapter 2: The burden of HPV-related cancers. Vaccine 24(Suppl 3):S3\/11\u2013S3\/25","journal-title":"Vaccine"},{"key":"3640_CR17","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1097\/QAD.0b013e328331d384","volume":"23","author":"MT van Leeuwen","year":"2009","unstructured":"van Leeuwen MT, Vajdic CM, Middleton MG et al (2009) Continuing declines in some but not all HIV-associated cancers in Australia after widespread use of antiretroviral therapy. AIDS 23:2183\u20132190","journal-title":"AIDS"},{"issue":"20","key":"3640_CR18","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1093\/jnci\/djs371","volume":"104","author":"MS Shiels","year":"2012","unstructured":"Shiels MS, Pfeiffer RM, Chaturvedi AK, Kreimer AR, Engels EA (2012) Impact of the HIV epidemic on the incidence rates of anal cancer in the United States. J Natl Cancer Inst 104(20):1591\u20131598 [PubMed: 23042932])","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"3640_CR19","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1097\/QAD.0b013e328331f6e2","volume":"24","author":"NF Crum-Cianflone","year":"2010","unstructured":"Crum-Cianflone NF, Hullsiek KH, Marconi VC, Ganesan A, Weintrob A, Barthel RV, Agan BK, Infectious Disease Clinical Research Program HIV Working Group (2010) Anal cancers among HIV-infected persons: HAART is not slowing rising incidence. AIDS. 24(4):535\u2013543. https:\/\/doi.org\/10.1097\/QAD.0b013e328331f6e2","journal-title":"AIDS."},{"key":"3640_CR20","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1097\/QAI.0b013e31817aebfe","volume":"48","author":"G D\u2019Souza","year":"2008","unstructured":"D\u2019Souza G, Wiley DJ, Li X et al (2008) Incidence and epidemiology of anal cancer in the multicenter AIDS cohort study. J Acquir Immune Defic Syndr 48:491\u2013499","journal-title":"J Acquir Immune Defic Syndr"},{"key":"3640_CR21","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1097\/QAD.0000000000000382","volume":"28","author":"M Hleyhel","year":"2014","unstructured":"Hleyhel M, Bouvier AM, Belot A et al (2014) Risk of non-AIDS-defining cancers among HIV-1-infected individuals in France between 1997 and 2009: results from a French cohort. AIDS. 28:2109\u20132118. https:\/\/doi.org\/10.1097\/QAD.0000000000000382","journal-title":"AIDS."},{"issue":"7","key":"3640_CR22","first-page":"199","volume":"108","author":"H Tuite","year":"2015","unstructured":"Tuite H, Horgan M, Mallon PWG, McConkey SJ, Mooka B, Mulcahy F et al (2015) Patients accessing ambulatory care for HIV-Infection: epidemiology and prevalence assessment. Irish Medical Journal July\/August 108(7):199\u2013201","journal-title":"Irish Medical Journal July\/August"},{"issue":"3","key":"3640_CR23","doi-asserted-by":"publisher","first-page":"e0150546","DOI":"10.1371\/journal.pone.0150546","volume":"11","author":"S O\u2019Connell","year":"2016","unstructured":"O\u2019Connell S, Lillis D, Cotter A et al (2016) Opt-Out panel testing for HIV, hepatitis B and hepatitis C in an urban emergency department: A Pilot Study. PLoS One 11(3):e0150546. Published 2016 Mar 11. https:\/\/doi.org\/10.1371\/journal.pone.0150546","journal-title":"PLoS One"},{"key":"3640_CR24","unstructured":"Kerr C, Heskin J, Shaw G, Craig J, Bergin C A description of demographic data of HIV positive MSM patients attending St. James\u2019s Hospital in 2018 and an audit of HPV vaccination rates among this cohort from 2014-2018. In: Poster Presentation at the Irish Infectious Disease Society of Ireland, May 2019"},{"key":"3640_CR25","unstructured":"Howlader N, Noone AM, Krapcho M, Miller D, Brest A, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2016, National Cancer Institute. Bethesda, MD, https:\/\/seer.cancer.gov\/csr\/1975_2016\/, based on November 2018 SEER data submission, posted to the SEER web site, April 2019."},{"issue":"16","key":"3640_CR26","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1097\/QAD.0000000000001639","volume":"31","author":"ML Siegenbeek van Heukelom","year":"2017","unstructured":"Siegenbeek van Heukelom ML, Marra E, de Vries HJC, Schim van der Loeff MF, Prins JM (2017) Risk factors for anal high-grade squamous intraepithelial lesions in HIV-positive MSM: is targeted screening possible? AIDS. 31(16):2295\u20132301. https:\/\/doi.org\/10.1097\/QAD.0000000000001639","journal-title":"AIDS."},{"key":"3640_CR27","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1097\/QAD.0000000000001045","volume":"30","author":"AM Schofield","year":"2016","unstructured":"Schofield AM, Sadler L, Nelson L, Gittins M, Desai M, Sargent A, McMahon RF, Hill J, Crosbie EJ, Patnick J, Kitchener HC (2016) A prospective study of anal cancer screening in HIV-positive and negative MSM. AIDS 30:1375\u20131383. https:\/\/doi.org\/10.1097\/QAD.0000000000001045","journal-title":"AIDS"},{"key":"3640_CR28","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1097\/QAI.0000000000000910","volume":"71","author":"G D\u2019Souza","year":"2016","unstructured":"D\u2019Souza G, Wentz A, Wiley D et al (2016) Anal cancer screening in men who have sex with men in the multicenter AIDS cohort study. J Acquir Immune Defic Syndr. 71:570\u2013576","journal-title":"J Acquir Immune Defic Syndr."},{"key":"3640_CR29","doi-asserted-by":"crossref","unstructured":"Bertoli HK, Thomsen LT, Iftner T, Dehlendorff C, Kj\u00e6r SK (2020 Jan) Risk of vulvar, vaginal and anal high-grade intraepithelial neoplasia and cancer according to cervical human papillomavirus (HPV) status: a population-based prospective cohort study. Gynecol Oncol. 30","DOI":"10.1016\/j.ygyno.2020.01.030"},{"key":"3640_CR30","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1007\/BF02586980","volume":"17","author":"ND Nigro","year":"1974","unstructured":"Nigro ND, Vaitkevicius VK, Considine B (1974) Combined therapy for cancer of the anal canal: a preliminary report. Dis Colon Rectum 17:354\u2013356","journal-title":"Dis Colon Rectum"},{"issue":"9034","key":"3640_CR31","first-page":"1049e54","volume":"348","author":"Epidermoid anal cancer","year":"1996","unstructured":"Epidermoid anal cancer (1996) Results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Committee on Cancer Research. Lancet 348(9034):1049e54","journal-title":"Lancet"},{"key":"3640_CR32","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1016\/j.ejso.2014.07.030","volume":"40","author":"R Glynne-Jones","year":"2014","unstructured":"Glynne-Jones R, Nilsson PJ, Aschelle C et al (2014) Anal cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up. Eur J Surg Oncol 40:1165\u20131176","journal-title":"Eur J Surg Oncol"},{"issue":"9","key":"3640_CR33","doi-asserted-by":"publisher","first-page":"2527e39","DOI":"10.1200\/JCO.1996.14.9.2527","volume":"14","author":"M Flam","year":"1996","unstructured":"Flam M, John M, Pajak TF, Petrelli N, Myerson R, Doggett S et al (1996) Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study. J Clin Oncol 14(9):2527e39","journal-title":"J Clin Oncol"},{"key":"3640_CR34","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1038\/sj.bjc.6605605","volume":"102","author":"J Northover","year":"2010","unstructured":"Northover J, Glynne-Jones R, Sebag-Montefiore D, James R, Meadows H, Wan S, Jitlal M, Ledermann J (2010) Chemoradiation for the treatment of epidermoid anal cancer: 13-year follow-up of the first randomised UKCCCR Anal Cancer Trial (ACT I). Br J Cancer 102:1123\u20131128. https:\/\/doi.org\/10.1038\/sj.bjc.6605605","journal-title":"Br J Cancer"},{"key":"3640_CR35","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1200\/JCO.1997.15.5.2040","volume":"15","author":"H Bartelink","year":"1997","unstructured":"Bartelink H, Roelofsen F, Eschwege F, Rougier P, Bosset JF, Gonzalez DG, Peiffert D, van Glabbeke M, Pierart M (1997) Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J Clin Oncol 15:2040\u20132049","journal-title":"J Clin Oncol"},{"issue":"7","key":"3640_CR36","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1038\/sj.bjc.6605605","volume":"102","author":"A Downing","year":"2010","unstructured":"Downing A, Morris EJ, Aravani A et al (2010 Mar 30) The effect of the UK Coordinating Centre for Cancer Research Anal Cancer Trial (ACT1) on population-based treatment and survival for squamous cell cancer of the anus. Br J Cancer. 102(7):1123\u20131128","journal-title":"Br J Cancer."},{"key":"3640_CR37","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1001\/jama.299.16.1914","volume":"299","author":"JA Ajani","year":"2008","unstructured":"Ajani JA, Winter KA, Gunderson LL et al (2008) Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial. JAMA 299:1914\u20131921","journal-title":"JAMA"},{"issue":"35","key":"3640_CR38","doi-asserted-by":"publisher","first-page":"4344","DOI":"10.1200\/JCO.2012.43.8085","volume":"30","author":"LL Gunderson","year":"2012","unstructured":"Gunderson LL, Winter KA, Ajani JA, Pedersen JE, Moughan J, Benson AB III, Thomas CR Jr, Mayer RJ, Haddock MG, Rich TA, Willett CG (2012) Long-term update of US GI intergroup RTOG 98-11 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil\/mitomycin versus fluorouracil\/cisplatin. J Clin Oncol. 30(35):4344\u20134351","journal-title":"J Clin Oncol."},{"key":"3640_CR39","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/S1470-2045(13)70086-X","volume":"14","author":"RD James","year":"2013","unstructured":"James RD, Glynne-Jones R, Meadows HM, Cunningham D, Myint AS, Saunders MP, Maughan T, McDonald A, Essapen S, Leslie M, Falk S, Wilson C, Gollins S, Begum R, Ledermann J, Kadalayil L, Sebag-Montefiore D (2013) Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2 x 2 factorial trial. Lancet Oncol 14:516\u2013524","journal-title":"Lancet Oncol"},{"key":"3640_CR40","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1200\/JCO.2011.35.4837","volume":"30","author":"D Peiffert","year":"2012","unstructured":"Peiffert D, Tournier-Rangeard L, G\u00e9rard JP, Lemanski C, Fran\u00e7ois E, Giovannini M, Cvitkovic F, Mirabel X, Bouch\u00e9 O, Luporsi E, Conroy T, Montoto-Grillot C, Mornex F, Lusinchi A, Hannoun-L\u00e9vi JM, Seitz JF, Adenis A, Hennequin C, Denis B, Ducreux M (2012) Induction chemotherapy and dose intensification of the radiation boost in locally advanced anal canal carcinoma: final analysis of the randomized UNICANCER ACCORD 03 trial. J Clin Oncol 30:1941\u20131948","journal-title":"J Clin Oncol"},{"issue":"2","key":"3640_CR41","doi-asserted-by":"publisher","first-page":"139e62","DOI":"10.3322\/caac.21259","volume":"65","author":"R Shridhar","year":"2015","unstructured":"Shridhar R, Shibata D, Chan E, Thomas CR (2015) Anal cancer: current standards in care and recent changes in practice. CA Cancer J Clin 65(2):139e62","journal-title":"CA Cancer J Clin"},{"issue":"36","key":"3640_CR42","doi-asserted-by":"publisher","first-page":"13052","DOI":"10.3748\/wjg.v20.i36.13052","volume":"20","author":"MC Osborne","year":"2014","unstructured":"Osborne MC, Maykel J, Johnson EK, Steele SR (2014) Anal squamous cell carcinoma: an evolution in disease and management. World J Gastroenterol. 20(36):13052\u201313059. https:\/\/doi.org\/10.3748\/wjg.v20.i36.13052","journal-title":"World J Gastroenterol."},{"key":"3640_CR43","doi-asserted-by":"publisher","first-page":"651","DOI":"10.2147\/OTT.S38217","volume":"6","author":"S Weis","year":"2013","unstructured":"Weis S (2013) Current treatment options for management of anal intraepithelial neoplasia. OncoTargets and Therapy. 6:651\u2013665","journal-title":"OncoTargets and Therapy."},{"issue":"1","key":"3640_CR44","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1080\/17843286.2015.1116725","volume":"72","author":"N Willems","year":"2017","unstructured":"Willems N, Libois A, Nkuize M, Feoli F, Delforge M, DeWit S (2017) Treatment of anal dysplasia in HIV-positive men who have sex with men in a large AIDS reference centre. Acta Clinica Belgica 72(1):29\u201335","journal-title":"Acta Clinica Belgica"},{"key":"3640_CR45","doi-asserted-by":"crossref","unstructured":"Anal intraepithelial neoplasia: a review of diagnosis and management. Joseph R Roberts, Lacey L Siekas, Andrew M Kaz. World J Gastrointest Oncol 2017 February 15; 9(2): 50-61","DOI":"10.4251\/wjgo.v9.i2.50"},{"key":"3640_CR46","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1097\/AOG.0000000000001135","volume":"126","author":"K Robison","year":"2015","unstructured":"Robison K, Cronin B, Bregar A, Luis C, DiSilvestro P, Schechter S, Pisharodi L, Raker C, Clark M (2015) Anal cytology and human papillomavirus genotyping in women with a history of lower genital tract neoplasia compared with low-risk women. Obstet Gynecol 126:1294\u20131300. https:\/\/doi.org\/10.1097\/AOG.0000000000001135","journal-title":"Obstet Gynecol"},{"key":"3640_CR47","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1001\/jama.281.19.1822","volume":"281","author":"SJ Goldie","year":"1999","unstructured":"Goldie SJ, Kuntz KM, Weinstein MC, Freedberg KA, Welton ML, Palefsky JM (1999) The clinical effectiveness and cost-effectiveness of screening for anal squamous intraepithelial lesions in homosexual and bisexual HIV-positive men. JAMA 281:1822\u20131829","journal-title":"JAMA"},{"key":"3640_CR48","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1093\/cid\/cir1036]45","volume":"54","author":"KA Swedish","year":"2012","unstructured":"Swedish KA, Factor SH, Goldstone SE (2012) Prevention of recurrent high-grade anal neoplasia with quadrivalent human papillomavirus vaccination of men who have sex with men: a nonconcurrent cohort study. Clin Infect Dis 54:891\u2013898. https:\/\/doi.org\/10.1093\/cid\/cir1036]45","journal-title":"Clin Infect Dis"},{"key":"3640_CR49","doi-asserted-by":"publisher","first-page":"6941","DOI":"10.1016\/j.vaccine.2014.10.052","volume":"32","author":"AA Deshmukh","year":"2014","unstructured":"Deshmukh AA, Chiao EY, Das P, Cantor SB (2014) Clinical effectiveness and cost-effectiveness of quadrivalent human papillomavirus vaccination in HIV-negative men who have sex with men to prevent recurrent high-grade anal intraepithelial neoplasia. Vaccine 32:6941\u20136947. https:\/\/doi.org\/10.1016\/j.vaccine.2014.10.052","journal-title":"Vaccine"}],"container-title":["International Journal of Colorectal Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00384-020-03640-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00384-020-03640-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00384-020-03640-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,3]],"date-time":"2021-06-03T23:37:24Z","timestamp":1622763444000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00384-020-03640-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,4]]},"references-count":49,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["3640"],"URL":"https:\/\/doi.org\/10.1007\/s00384-020-03640-9","relation":{},"ISSN":["0179-1958","1432-1262"],"issn-type":[{"value":"0179-1958","type":"print"},{"value":"1432-1262","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,4]]},"assertion":[{"value":"14 May 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Approval was granted by the institution\u2019s ethics committee prior to receiving access to the local cancer database.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}